These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10726756)

  • 1. Analysis of the NF1 gene by temperature gradient gel electrophoresis reveals a high incidence of mutations in exon 4b.
    Toliat MR; Erdogan F; Gewies A; Fahsold R; Buske A; Tinschert S; Nürnberg P
    Electrophoresis; 2000 Feb; 21(3):541-4. PubMed ID: 10726756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three novel mutations of the NF1 gene detected by temperature gradient gel electrophoresis of exons 5 and 8.
    Horn D; Robinson PN; Böddrich A; Buske A; Tinschert S; Nürnberg P
    Electrophoresis; 1996 Oct; 17(10):1559-63. PubMed ID: 8957181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene.
    Upadhyaya M; Osborn M; Maynard J; Harper P
    Am J Med Genet; 1996 Jul; 67(4):421-3. PubMed ID: 8837715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene.
    Böddrich A; Griesser J; Horn D; Kaufmann D; Krone W; Nürnberg P
    Biochem Biophys Res Commun; 1995 Sep; 214(3):895-904. PubMed ID: 7575561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 ( NF1) gene.
    Han SS; Cooper DN; Upadhyaya MN
    Hum Genet; 2001 Nov; 109(5):487-97. PubMed ID: 11735023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF1 gene analysis based on DHPLC.
    De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
    Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
    Messiaen LM; Callens T; Mortier G; Beysen D; Vandenbroucke I; Van Roy N; Speleman F; Paepe AD
    Hum Mutat; 2000; 15(6):541-55. PubMed ID: 10862084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.
    Kinoshita K; Hirota S; Isozaki K; Ohashi A; Nishida T; Kitamura Y; Shinomura Y; Matsuzawa Y
    J Pathol; 2004 Jan; 202(1):80-5. PubMed ID: 14694524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two independent mutations in a family with neurofibromatosis type 1 (NF1).
    Klose A; Peters H; Hoffmeyer S; Buske A; Lüder A; Hess D; Lehmann R; Nürnberg P; Tinschert S
    Am J Med Genet; 1999 Mar; 83(1):6-12. PubMed ID: 10076878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of neurofibromatosis type 1 mutations.
    Weiming X; Yu Q; Lizhi L; Ponder M; Wallace M; Gangfeng X; Ponder B
    Hum Mutat; 1992; 1(6):474-7. PubMed ID: 1301957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberous sclerosis type 1: three novel mutations detected in exon 15 by a combination of HDA and TGGE.
    Hass J; Mayer K; Rott HD
    Hum Mutat; 2000 Jul; 16(1):88. PubMed ID: 10874311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of NF1 gene mutations in neurofibromatosis type 1 patients in Japan.
    Hatta N; Horiuchi T; Fujita S
    Biochem Biophys Res Commun; 1994 Feb; 199(1):207-12. PubMed ID: 8123014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the non-deletion alpha-thalassemia mutations by PCR temperature gradient gel electrophoresis].
    Zhao Y; Xu X; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Feb; 18(1):51-5. PubMed ID: 11172644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
    Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
    Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of germline mutations in the BRCA1 gene by RNA-based sequencing.
    Jakubowska A; Górski B; Byrski T; Huzarski T; Gronwald J; Menkiszak J; Cybulski C; Debniak T; Hadaczek P; Scott RJ; Lubinski J
    Hum Mutat; 2001 Aug; 18(2):149-56. PubMed ID: 11462239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic analyses in neurofibromatosis type 1 patients with tumors.
    Oguzkan S; Terzi YK; Cinbis M; Anlar B; Aysun S; Ayter S
    Cancer Genet Cytogenet; 2006 Mar; 165(2):167-71. PubMed ID: 16527612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of novel NF1 mutations and rapid mutation prescreening with Pyrosequencing.
    Brinckmann A; Mischung C; Bässmann I; Kühnisch J; Schuelke M; Tinschert S; Nürnberg P
    Electrophoresis; 2007 Dec; 28(23):4295-301. PubMed ID: 18041031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in NF1 patients with malignancies.
    Wu R; López-Correa C; Rutkowski JL; Baumbach LL; Glover TW; Legius E
    Genes Chromosomes Cancer; 1999 Dec; 26(4):376-80. PubMed ID: 10534774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.